此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Evaluation of SofWave Sofware-Guided Energy Delivery for Lower Face and Neck Rejuvenation

2026年7月23日 更新者:Sofwave Medical LTD
Non-randomized single-arm prospective clinical study.

研究概览

地位

尚未招聘

干预/治疗

详细说明

Eligible subjects will receive 1 or 2 SofWave treatments (4-6 weeks apart) using the Total Treatment Energy (TTE) methods and will return to 3 follow up visits: at 4 weeks ± 2 weeks post last treatment (FU1), at 12 weeks ± 2 weeks post last treatment (FU2) , at 24 weeks ± 4 weeks post last treatment (FU3).

研究类型

介入性

注册 (估计的)

30

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

    • Texas
      • Houston、Texas、美国、77004
        • Dermatology & Laser Surgery Center
        • 首席研究员:
          • Paul Friedman, MD
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人

接受健康志愿者

是的

描述

Inclusion Criteria:

  1. Healthy female and male subjects between the ages 40-55.
  2. Non-Smoker.
  3. Fitzpatrick skin type I-VI.
  4. Desire to lift facial lax skin, neck and/or submental and/or improve facial wrinkles appearance.
  5. Presence of mild to moderate laxity in the lower face and submental area.
  6. Able and willing to comply with all visits, treatments and evaluation schedules and requirements.
  7. Able to understand and provide written Informed Consent.
  8. Women of child-bearing age are required to be using a reliable method of birth control at least 3 months prior to study enrollment.
  9. Subject agrees not to undergo any other facial cosmetic treatment for a period of 3 months following last SofWave treatment.
  10. Stable weight over the last 12 weeks and throughout the duration of the study.
  11. Subjects agree to adhere to safe sun practices and daily use of broad-spectrum sunscreen SPF 30+.
  12. Male subjects with facial hair in the treatment area are willing to trim or shave as needed to allow consistent standardized photography.

    -

Exclusion Criteria:

  1. Pregnant or planning to become pregnant, having given birth less than 3 months ago, and/or breast feeding.
  2. Presence of any active systemic or local infections.
  3. Open wounds or lesions within the intended to treat area.
  4. Tattoo or former tattoo at or near treatment area.
  5. Presence of active local skin disease that may alter wound healing.
  6. Uncontrolled diabetes mellitus.
  7. Skin cancer in the area to be treated. History of any other non-melanoma skin cancers in the past 5 years within the treatment area (head and neck).
  8. Severe solar elastosis.
  9. History of smoking in the past 10 years.
  10. History of chronic drug or alcohol abuse.
  11. Excessive subcutaneous fat on the cheeks.
  12. Significant scarring in the area to be treated or history of keloids.
  13. Severe or cystic facial acne, and/or Accutane use during the past 6 months.
  14. Pacemakers and electronic device implants in the treated area.
  15. Presence of a metal stent or implant in the facial area (dental implants and/or braces are not excluded).
  16. Inability to understand the protocol or to provide a signed informed consent.
  17. History of cosmetic treatments in the area to be treated including:

    • Chemical peels, microneedling, dermabrasion, energy-based devices, or laser treatments in the past 6 months
    • Injectable filler treatments in the past 6 months
    • Injectable neuromodulator treatment in the past 4 months
  18. Cosmetic surgical procedures in the treatment area, including but not limited to facelift in the past 12 months.
  19. Taking anti-platelet or anti-coagulant within the past 2 weeks.
  20. Ongoing use of psychiatric medication; taking psychiatric drugs within the past 2 weeks.
  21. As per the investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study.

    -

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Experimental: lax tissue
The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Evaluate the clinical efficacy of the treatment for lower face and upper neck rejuvenation
大体时间:12 weeks post treatment follow-up visit
Rate of the Improvement in the appearance of lower face and upper neck rejuvenation following SofWave treatment based on Global Aesthetic Improvement Scale (-1=worse, 0=no change, 1=improved, 2=marked improvement, 3=very much improved)
12 weeks post treatment follow-up visit
Lower face and upper neck rejuvenation
大体时间:12 weeks post treatment follow-up visit
Evaluate the clinical efficacy of the treatment for lower face and upper neck rejuvenation, as assessed by the study physician using Physician Global Aesthetic Improvement Scale (GAIS; (-1=worse, 0=no change, 1=improved, 2=marked improvement, 3=very much improved)) at 12 weeks follow-up visit.
12 weeks post treatment follow-up visit

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年7月20日

初级完成 (估计的)

2027年7月15日

研究完成 (估计的)

2027年7月15日

研究注册日期

首次提交

2026年7月19日

首先提交符合 QC 标准的

2026年7月19日

首次发布 (实际的)

2026年7月23日

研究记录更新

最后更新发布 (实际的)

2026年7月27日

上次提交的符合 QC 标准的更新

2026年7月23日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

是的

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅